Abstract
Global Opioid-Induced Constipation (OIC) Treatment Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Opioid-Induced Constipation (OIC) Treatment market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026.
Opioid-Induced Constipation (OIC) Treatment Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
By geography, this market has been segregated into five regions with revenue and growth rate of Opioid-Induced Constipation (OIC) Treatment from 2013 to 2026,
• North America (U.S., Canada, Mexico)
• Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
• Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
• Latin America (Brazil, Rest of L.A.)
• Middle East And Africa(Turkey, GCC, Rest of Middle East)
The major players operating into Opioid-Induced Constipation (OIC) Treatment Market include:
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
This report segments the Global Opioid-Induced Constipation (OIC) Treatment Market as follows:
Global Opioid-Induced Constipation (OIC) Treatment Market: Type Segment Analysis
Oral
Parenteral (Subcutaneous Injection)
Global Opioid-Induced Constipation (OIC) Treatment Market: Application Segment Analysis
Drug Store
Independent Pharmacies
Hospital Pharmacies
There are 13 chapters to put on view for Opioid-Induced Constipation (OIC) Treatment Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
Chapter 2: Market competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Opioid-Induced Constipation (OIC) Treatment Research Findings and Conclusion, Appendix, methodology and data source
Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.
Industry Chain Analysis
Raw Material and Suppliers
Equipment and Suppliers
Manufacturing Process
Manufacturing Cost Structure
Manufacturing Plants Distribution Analysis
Available Customizations
We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview
1.1 Opioid-Induced Constipation (OIC) Treatment Market Overview
1.1.1 Opioid-Induced Constipation (OIC) Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Opioid-Induced Constipation (OIC) Treatment Market Size and Analysis by Regions (2014-2019)
1.2.1 North America Opioid-Induced Constipation (OIC) Treatment Market Status and Outlook
1.2.2 EU Opioid-Induced Constipation (OIC) Treatment Market Status and Outlook
1.2.3 Japan Opioid-Induced Constipation (OIC) Treatment Market Status and Outlook
1.2.4 China Opioid-Induced Constipation (OIC) Treatment Market Status and Outlook
1.2.5 India Opioid-Induced Constipation (OIC) Treatment Market Status and Outlook
1.2.6 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Status and Outlook
1.3 Global Opioid-Induced Constipation (OIC) Treatment Market Segment by Types (2014-2025)
1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate Comparison by Types (2014-2025)
1.3.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Types in 2018
1.3.3 Oral
1.3.4 Parenteral (Subcutaneous Injection)
1.3.5 Type 3
Others
1.4 Opioid-Induced Constipation (OIC) Treatment Market by End Users/Application
1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue (USD Mn) Comparison by Applications (2014-2025)
1.4.1 Drug Store
1.4.2 Independent Pharmacies
1.4.3 Hospital Pharmacies
Others
Chapter 2 Global Opioid-Induced Constipation (OIC) Treatment Competition Analysis by Players
2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size (Million USD) by Players (2014-2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
Chapter 3 Company (Top Players) Profiles and Key Data
3.1 GlaxoSmithKline
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 GlaxoSmithKline, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) (2014-2019)
3.1.5 Recent Developments
3.2 AstraZeneca
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 AstraZeneca, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) (2014-2019)
3.2.5 Recent Developments
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Pfizer, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) (2014-2019)
3.3.5 Recent Developments
3.4 S.L.A. Pharma
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 S.L.A. Pharma, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) (2014-2019)
3.4.5 Recent Developments
3.5 AIKO Biotechnology
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 AIKO Biotechnology, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD)(2014-2019)
3.5.5 Recent Developments
3.6 Cubist Pharmaceuticals
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cubist Pharmaceuticals, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD)(2014-2019)
3.6.5 Recent Developments
3.7 Salix Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Salix Pharmaceuticals, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD)(2014-2019)
3.7.5 Recent Developments
3.8 Takeda Pharmaceutical
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Takeda Pharmaceutical, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) (2014-2019)
3.8.5 Recent Developments
3.9 Player 9
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Player 9, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) (2014-2019)
3.9.5 Recent Developments
3.10 Player-10
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Player-10, Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) (2014-2019)
3.10.5 Recent Developments
Chapter 4 Global Opioid-Induced Constipation (OIC) Treatment Market Size Type (2014-2019)
4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2014-2019)
Chapter 5 Global Opioid-Induced Constipation (OIC) Treatment Market Size Application (2014-2019)
5.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)
5.2 Potential Application of Opioid-Induced Constipation (OIC) Treatment in Future
5.3 Top Consumer / End Users of Opioid-Induced Constipation (OIC) Treatment
Chapter 6 North America Opioid-Induced Constipation (OIC) Treatment Development Status and Outlook
6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)
Chapter 7 EU Opioid-Induced Constipation (OIC) Treatment Development Status and Outlook
7.1 EU Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
7.2 EU Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)
Chapter 8 Japan Opioid-Induced Constipation (OIC) Treatment Development Status and Outlook
8.1 Japan Opioid-Induced Constipation (OIC) Treatment Market Size (2014-2019)
8.2 Japan Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)
Chapter 9 China Opioid-Induced Constipation (OIC) Treatment Development Status and Outlook
9.1 China Opioid-Induced Constipation (OIC) Treatment Market Size and Forecast (2014-2019)
9.2 China Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)
Chapter 10 India Opioid-Induced Constipation (OIC) Treatment Development Status and Outlook
10.1 India Opioid-Induced Constipation (OIC) Treatment Market Size and Forecast (2014-2019)
10.2 India Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)
Chapter 11 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Development Status and Outlook
11.1 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size and Forecast (2014-2019)
11.2 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2014-2019)
Chapter 12 Market Forecast by Regions and Application (2019-2025)
12.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size (Million USD) by Regions (2019-2025)
12.1. North America Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate (2019-2025)
12.1.2 EU Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate (2019-2025)
12.1.3 China Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate (2019-2025)
12.1.4 Japan Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate (2019-2025)
12.1.5 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate (2019-2025)
12.1.6 India Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate (2019-2025)
12.2 Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2025)
Chapter 13 Opioid-Induced Constipation (OIC) Treatment Market Dynamics
13.1 Opioid-Induced Constipation (OIC) Treatment Market Opportunities
13.2 Opioid-Induced Constipation (OIC) Treatment Challenge and Risk
13.2.1 Competition from Opponents
13.2.2 Downside Risks of Economy
13.3 Opioid-Induced Constipation (OIC) Treatment Market Constraints and Threat
13.3.1 Threat from Substitute
13.3.2 Government Policy
13.3.3 Technology Risks
13.4 Opioid-Induced Constipation (OIC) Treatment Market Driving Force
13.4.1 Growing Demand from Emerging Markets
13.4.2 Potential Application
Chapter 14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs Trend/Customer Preference
14.3 External Environmental Change
14.3.1 Economic Fluctuations
14.3.2 Other Risk Factors
Chapter 15 Research Finding /Conclusion
Chapter 16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List
